ARTICLE | Distillery Therapeutics

Therapeutics: MicroRNA-150 (miR-150); FMS-like tyrosine kinase 3 (FLT3; CD135); FMS-like tyrosine kinase 3 ligand (FLT3LG)

June 30, 2016 7:00 AM UTC

Patient sample, cell culture and mouse studies suggest miR-150, a negative regulator of FLT3, could help treat FLT3-driven AML and mixed lineage leukemia (MLL). miR-150 levels were lower in blood mono...